Europe’s record West Nile virus outbreak raises economic alarm for UK

**Lead**

Europe has registered its highest ever number of West Nile virus infections this transmission season, according to the European Centre for Disease Prevention and Control (ECDC). While the UK remains free of locally acquired cases, the record outbreak on the continent is already having measurable economic consequences for British businesses, insurers and the National Health Service. The surge – concentrated in southern and central Europe – threatens to disrupt summer travel patterns, inflate healthcare costs and force a re‑evaluation of climate‑related disease preparedness in the United Kingdom.

**Context**

West Nile virus is a mosquito‑borne disease that can cause severe neurological illness in humans. The ECDC has reported that the number of human cases in the European Union and European Economic Area this year has surpassed all previous annual totals. Outbreaks have been particularly severe in Italy, Greece, Spain and Hungary, with the virus also detected in parts of France and Germany. The UK has never recorded a locally transmitted case; all infections identified in Britain have been in travellers returning from affected regions. However, the sheer scale of the European outbreak means that the number of imported cases arriving at UK ports and airports is expected to rise significantly.

The UK Health Security Agency (UKHSA) maintains a surveillance programme for vector‑borne diseases, but the economic burden of testing, contact tracing and, in rare severe cases, hospitalisation falls on the NHS. Each imported case that requires intensive care can cost tens of thousands of pounds. Moreover, the risk of the virus establishing a local transmission cycle in the UK – though still considered low – is increasing as climate change makes southern England warmer and wetter, conditions that favour the Culex mosquitoes that carry the virus. A 2023 report from the UK Climate Change Committee warned that without further adaptation, the economic cost of vector‑borne diseases could reach hundreds of millions of pounds by mid‑century.

**Analysis**

The economic implications for the UK extend beyond direct healthcare spending. The travel and tourism sector, which contributes more than £100 billion annually to the British economy, is sensitive to disease outbreaks in popular European destinations. British holidaymakers may cancel or postpone trips to affected regions, hitting airlines, hotels and tour operators. Insurers are already reviewing policies: some have begun to exclude cover for West Nile virus‑related claims in high‑risk areas, a move that could reduce consumer confidence and increase the cost of travel insurance. The Association of British Insurers has noted that while the current outbreak has not yet triggered widespread exclusions, the trend is being monitored closely.

Trade could also be affected. The UK imports a significant volume of fresh produce from southern Europe, including fruit, vegetables and olive oil. Outbreaks of vector‑borne diseases can lead to temporary restrictions on the movement of goods or labour shortages in agricultural regions. In Italy, for example, the peak of the West Nile season coincides with the harvest of tomatoes and grapes. If farm workers fall ill or are unable to work due to public health measures, supply chains could be disrupted, pushing up prices for British consumers. The UK’s departure from the European Union has already added friction to food imports; any additional disruption would amplify inflationary pressures.

Another dimension is the cost of preparedness. The UKHSA has stepped up its mosquito surveillance programme, deploying additional traps at ports and airports and expanding laboratory capacity to test for the virus. Local authorities in areas with large numbers of returning travellers – such as London, Manchester and Birmingham – are being asked to review their vector control plans. These measures, while necessary, divert resources from other public health priorities. The Treasury will have to decide whether to allocate additional funding to the UKHSA’s emerging infections budget, or to absorb the costs within existing departmental spending. Either way, the fiscal impact is non‑negligible.

Climate change is the underlying driver that makes the economic calculus more urgent. Warmer winters and longer summers extend the breeding season of mosquitoes and increase the likelihood that the virus can overwinter in temperate climates. A study published in *The Lancet Planetary Health* projected that by 2050, large parts of southern England could have climatic conditions suitable for West Nile virus transmission during the summer months. If that scenario materialises, the UK would face not only the cost of treating locally acquired cases but also the expense of large‑scale mosquito control programmes, public information campaigns and potential impacts on livestock (horses are also susceptible). The agricultural sector, already under pressure from rising input costs, would have to invest in biosecurity measures.

**Fontes**

- European Centre for Disease Prevention and Control (ECDC) – weekly West Nile virus updates and annual epidemiological reports. - UK Health Security Agency (UKHSA) – surveillance data and risk assessments for vector‑borne diseases. - UK Climate Change Committee – “Adapting to Climate Change: Progress Report 2023”. - Association of British Insurers – guidance on travel insurance and infectious disease exclusions. - *The Lancet Planetary Health* – “Projected climate suitability for West Nile virus transmission in Europe under different warming scenarios” (2022).